←
Dr. Shelly Xuelai Fan3,600 posts
Dr. Shelly Xuelai Fan avatar

Dr. Shelly Xuelai Fan

@ShellyFan

Neuroscientist/writer @singularityhub. Wrote a book: Will AI Replace Us? tinyurl.com/yxokn4rn. Pitch me: shelly.xuelai.fan@gmail.

◷ Joined January 2010▧ 141 Photos and videos
Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs) avatar
⟳ Dr. Shelly Xuelai Fan retweeted
Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs)@biogerontology·19 Mar 2024

An AI-Designed Drug Is Moving Toward Approval at an Impressive Clip by @ShellyFan #AI #Biopharma singularityhub.com/2024/03/1… via @Singularity Hub

Phil Leung avatar
⟳ Dr. Shelly Xuelai Fan retweeted
Phil Leung@proleu·22 Aug 2023

Thank you @ShellyFan for this great summary of our work and for including "Flip Flop" in the article (sounds a lot like Phil-ip FloP, which is what @FloPraetorius and I called the hinges for a while) singularityhub.com/2023/08/2… #AI #ProteinDesign

Samagya Banskota avatar
⟳ Dr. Shelly Xuelai Fan retweeted
Samagya Banskota@samagyabanskota·19 Jan 2022

Thank you @ShellyFan for the clearest (read, picturesque) explanation of our work @liugroup @davidrliu. While reading, I thought, "Wow, even my grandparents will understand my work! Finally!" Well someone will 1st have to translate this into Nepali.😄 🙏🙏 singularityhub.com/2022/01/1…

Dr. Shelly Xuelai Fan avatar
Dr. Shelly Xuelai Fan@ShellyFan·11 Oct 2021

Science folks! Some help with jargon-y grammar? Is it [pick your fav post-translational mod] on [residue] or [PTM] at [residue]? I've always used "at" but apparently people use "on" as well? "Phosphorylation on S###" just sounds wrong to me. 🤷‍♀️

Ian Kremer avatar
⟳ Dr. Shelly Xuelai Fan retweeted
Ian Kremer@LEAD_Coalition·30 Jul 2021

If you believe #healthequity is essential to advancing the #science we need to overcome #Alzheimers disease and other forms of #dementia, please urge Congress to pass the #ENACTAct. #ENDALZ #AAIC21 #StrongerTogether #ScienceMatters #JusticeMatters

Alzheimer’s & other dementia disproportionately affect older Black and Hispanic Americans. Yet too often the clinical trial staff and participants don’t reflect the U.S. population. The #ENACTAct will address these shortcomings. Show your support: p2a.co/xuOMRgm. #ENDALZ